A Brainy Twist to Image Analysis

Courtesy of DefiniensBromodeoxyuridine-stained tissue of mouse small intestine (original image, left; and Cellenger analysis, right). Cellenger has extracted whole crypts on a larger scale and distinguishes between mitotic and non-mitotic nuclei on a smaller scale.Propelled by the pharmaceutical industry, the high-content imaging field has experienced rapid growth, with several major new instrument releases in the past two years. High-throughput image analysis has lagged behind, however, because

Written byAileen Constans
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Courtesy of Definiens

Bromodeoxyuridine-stained tissue of mouse small intestine (original image, left; and Cellenger analysis, right). Cellenger has extracted whole crypts on a larger scale and distinguishes between mitotic and non-mitotic nuclei on a smaller scale.

Propelled by the pharmaceutical industry, the high-content imaging field has experienced rapid growth, with several major new instrument releases in the past two years. High-throughput image analysis has lagged behind, however, because current software packages cannot keep pace with the huge amount of data these systems generate, says Martin Baatz, director of business development at Munich-based Definiens http://www.definiens.com. Definiens' new Cellenger software addresses this problem, providing fully automated quantitative analysis of biological images.

Cognition Network Technology, the platform on which Cellenger is based, was developed over the past nine years by Definiens' cofounder and Nobel laureate Gerd Binnig and his team. Initially written for the geoscience community, which used it to extract interesting objects ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies